首页 | 本学科首页   官方微博 | 高级检索  
     

血脂快速分析仪检测血脂的可靠性研究
引用本文:高莹,朱成刚,吴娜琼,郭远林,刘庚,董倩,李建军. 血脂快速分析仪检测血脂的可靠性研究[J]. 北京大学学报(医学版), 2016, 48(3): 523-528. DOI: 10.3969/j.issn.1671-167X.2016.03.025
作者姓名:高莹  朱成刚  吴娜琼  郭远林  刘庚  董倩  李建军
作者单位:(中国医学科学院阜外医院血脂异常与心血管疾病诊治中心, 北京100037)
基金项目:首都医学发展科研基金(2011400302)资助 Supported by the Capital Foundation for Medical Research and Development (2011400302)
摘    要:目的:评价血脂快速分析仪CardioChek PA(CCPA)快速检测血脂的可靠性。方法: 连续收集325例(23~86岁)阜外医院血脂中心入院患者的空腹血样,血清管采集第1份静脉血样并用Beckman分析仪检测血脂各成分,肝素锂管采集第2份静脉血样并使用CCPA分析仪检测,对二者的检测结果进行比较。采用线性回归分析和Bland-Altman法评价两种检测方法获得的总胆固醇(total cholesterol,TC)、高密度脂蛋白胆固醇(high density lipoprotein-cholesterol,HDL-C)、甘油三酯(triglycerides,TG)和低密度脂蛋白胆固醇(low density lipoprotein-cholesterol,LDL-C)的相关性。结果: CCPA检测结果与实验室检查结果具有良好的一致性,其TC、HDL-C、TG和LDL-C的相关系数分别为0.875、0.813、0.910、0.864,对回归方程中的变量有无回归关系进行方差分析,P均<0.001。两种检测方法检测TC、HDL-C、TG和LDL-C的临床一致百分比分别为97.0%、92.9%、92.4%和83.7%,两种检测方法血脂异常的检出率在TC、HDL-C和TG中没有统计学差异。结论: 在严格控制血样采集质量的基础上,CCPA快速血脂检测系统与实验室常规检测法具有良好相关性,是一种可靠的床旁临床血脂筛查工具。

关 键 词:血脂异常  床旁检测  心血管疾病  

Study on the reliability of CardioChek PA for measuring lipid profile
GAO Ying,ZHU Cheng-gang,WU Na-qiong,GUO Yuan-lin,LIU Geng,DONG Qian,LI Jian-jun. Study on the reliability of CardioChek PA for measuring lipid profile[J]. Journal of Peking University. Health sciences, 2016, 48(3): 523-528. DOI: 10.3969/j.issn.1671-167X.2016.03.025
Authors:GAO Ying  ZHU Cheng-gang  WU Na-qiong  GUO Yuan-lin  LIU Geng  DONG Qian  LI Jian-jun
Affiliation:(Department of Dyslipidemia and Cardiovascular Disease, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037, China)
Abstract:Objective:To evaluate the clinical correlation between the CardioChek PA analyzer (CCPA)and a clinical laboratory reference method to use for screening program purposes.Methods:Fasting blood samples were collected on 325 patients (age:23 -86 years).One venous sample was col-lected using a serum tube for the evaluation on a Beckman reference analyzer.A second venous sample was collected in a lithium heparin tube and was evaluated on the CCPA analyzer.Linear regression analy-ses and Bland-Altman method were performed for each measured analyte:total cholesterol (TC),high density lipoprotein-cholesterol (HDL-C),triglycerides (TG)and low density lipoprotein-cholesterol (LDL-C).Results:Our results demonstrated a good clinical agreement for TC,HDL-C,TG and LDL-C (97.0%,92.9%,92.4% and 83.7%)in comparison with the CCPA to the reference analyzer.The correlation coefficients were 0.875,0.81 3,0.91 0,0.864,respectively.P values all <0.001 .There was no significant difference in the detection rate of hyperlipidemia in TC,HDL-C and LDL-C.Conclu-sion:We have identified the pre-analytic phase as an important step to guarantee the quality of results and indicated that the CCPA is a reliable lipid point-of-care testing system that can be used for the appli-cation of clinical screening anywhere.
Keywords:Dyslipidemias  Point-of-care testing  Cardiovascular diseases
本文献已被 万方数据 等数据库收录!
点击此处可从《北京大学学报(医学版)》浏览原始摘要信息
点击此处可从《北京大学学报(医学版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号